Prorok PC

No ORCID on file · 3 papers in corpus
2016
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.08.334

BackgroundThe Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4years of follow-up. The UKCTOCS screening trial failed to show a s…

2012
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.12.440

ObjectiveTo determine whether CA-125 velocity is a statistically significant predictor of ovarian cancer and develop a classification rule to screen for ovarian cancer.MethodsIn the ovarian component of the PLCO cancer screening trial, 28,0…

rct 1993
Cancer ·doi:10.1002/cncr.2820710215

BACKGROUND. Ovarian cancer is the fifth most common cause of cancer-related death in American women. The median age at diagnosis is about 62 years; incidence rises rapidly after age 60. Pelvic examination has been the primary method for det…